Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry
- 30 July 2008
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 26 (2) , 117-123
Abstract
Aim To investigate whether the presence of CD147 and MMP-2 in cancerous gallbladder tissues might help us to predict the patients’ prognosis. Methods Tissue samples from 168 patients with gallbladder carcinomas and 37 patients with chronic cholecystitis were stained with anti-CD147 and anti-MMP-2 antibodies for immunohistochemical analysis. Then, the association of their expression with clinicopathologic characteristics and 108 patients’ prognosis was analyzed. Results CD147 and MMP-2 were detected mainly in cancerous tissues, but also expressed in some chronic cholecystitis patients. Out of 168 patients with gallbladder carcinoma 121 (72.02%) and 136 (80.95%) patients showed CD147 and MMP-2 positive expression, whereas the 37 patients with chronic cholecystitis only 5 (13.51%) and 3 (8.11%) patients expressed them, respectively. Pathologic findings demonstrated that the intensity of CD147 and MMP-2 staining in cancerous tissues was associated significantly with histological types (P = 0.03), distant metastasis (P < 0.01), and Nevin stages (P = 0.02) of gallbladder carcinomas. Using a proportional hazard model, the survival rate of the patients with CD147+/MMP-2+ expression was the lowest (P < 0.01), and including information on CD147 and MMP-2 staining patterns within cancerous tissues along with clinical cancer staging may improve the accuracy of predicting patients’ prognosis. Conclusion The results suggest that the expression of CD147 and MMP-2 may be an important feature of gallbladder carcinomas. The detection of these two markers combined with cancerous staging may increase the ability of investigators to predict the prognosis of patients with gallbladder carcinomas.Keywords
This publication has 18 references indexed in Scilit:
- EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese peopleAPMIS, 2007
- Thrombin-Cleaved COOH-Terminal Osteopontin Peptide Binds with Cyclophilin C to CD147 in Murine Breast Cancer CellsCancer Research, 2007
- Expression of Emmprin and matriptase in esophageal squamous cell carcinoma: Correlation with clinicopathological parametersDiseases of the Esophagus, 2006
- Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progressionPathology International, 2006
- High incidence of EMMPRIN expression in human tumorsInternational Journal of Cancer, 2006
- Differential Expression of Extracellular Matrix Metalloproteinase Inducer (CD147) in Normal and Ulcerated CorneasThe American Journal of Pathology, 2005
- Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T‐cell lymphomasThe Journal of Pathology, 2004
- Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan ProductionCancer Research, 2004
- The microvesicle as a vehicle for EMMPRIN in tumor–stromal interactionsOncogene, 2004
- Tumorigenic Potential of Extracellular Matrix Metalloproteinase InducerThe American Journal of Pathology, 2001